Literature DB >> 20677314

Praziquantel and schistosomiasis.

Alexander Dömling1, Kareem Khoury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20677314     DOI： 10.1002/cmdc.201000202

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  19 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

2.  Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against Schistosomiasis.

Authors:  Raghvendra Singh; Paras Nath Pandey
Journal:  Mol Biol Rep       Date:  2015-02-07       Impact factor: 2.316

Review 3.  New insight into praziquantel against various developmental stages of schistosomes.

Authors:  Wei Wu; Wei Wang; Yi-Xin Huang
Journal:  Parasitol Res       Date:  2011-10-08       Impact factor: 2.289

Review 4.  The redox biology of schistosome parasites and applications for drug development.

Authors:  Hsin-Hung Huang; Coraline Rigouin; David L Williams
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Effect of nanoparticles on the therapeutic efficacy of praziquantel against Schistosoma mansoni infection in murine models.

Authors:  Alaa Eldin M Labib El Gendy; Faten Alsayed Mohammed; Sara A Abdel-Rahman; Thanaa Ibrahim Ahmed Shalaby; Ghada M Fathy; Samira Metwally Mohammad; Mahmoud A El-Shafey; Nesma Atef Mohammed
Journal:  J Parasit Dis       Date:  2019-04-03

6.  MCR synthesis of praziquantel derivatives.

Authors:  Haixia Liu; Samia William; Eberhardt Herdtweck; Sanaa Botros; Alexander Dömling
Journal:  Chem Biol Drug Des       Date:  2012-01-30       Impact factor: 2.817

7.  Molluscicidal metabolites from an assemblage of Palmyra Atoll cyanobacteria.

Authors:  Alban R Pereira; Lena Etzbach; Niclas Engene; Rolf Müller; William H Gerwick
Journal:  J Nat Prod       Date:  2011-04-07       Impact factor: 4.050

8.  Characterization of potential drug targets farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase in Schistosoma mansoni.

Authors:  Peter D Ziniel; Janish Desai; Cynthia L Cass; Craig Gatto; Eric Oldfield; David L Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni.

Authors:  Stefano Guglielmo; Daniela Cortese; Francesca Vottero; Barbara Rolando; Valerie P Kommer; David L Williams; Roberta Fruttero; Alberto Gasco
Journal:  Eur J Med Chem       Date:  2014-07-03       Impact factor: 6.514

10.  Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni.

Authors:  Martin Marek; Srinivasaraghavan Kannan; Alexander-Thomas Hauser; Marina Moraes Mourão; Stéphanie Caby; Vincent Cura; Diana A Stolfa; Karin Schmidtkunz; Julien Lancelot; Luiza Andrade; Jean-Paul Renaud; Guilherme Oliveira; Wolfgang Sippl; Manfred Jung; Jean Cavarelli; Raymond J Pierce; Christophe Romier
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.